Sign In
Buy HALB
$0.0009
-0.0003 (-25.00%)
At Close: Jun 02, 2026
Halberd Corp. Issues Letter to Shareholders
08:00am, Monday, 26'th Aug 2024
JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) — Halberd Corporation (OTC PINK: HALB) today issued the following letter to its shareholders: Halberd Corp.
Halberd Corp. Issues Letter to Shareholders
08:00am, Monday, 26'th Aug 2024
JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to it shareholders: Halberd Corp. - Taking a Moment to Recenter Our Techni
Halberd Corp's (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results
08:00am, Wednesday, 24'th Jul 2024
Jackson Center, PA July 24, 2024 – Halberd Corporation (OTC-PINK: “HALB”) has announced encouraging preliminary outcomes from its Phase II testing at Mississippi State University (MSU) of its Tr
Halberd's Traumatic Brain Injury Treatment Projects Align with New U.S. House Bill
08:00am, Thursday, 09'th May 2024
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously. JACKSON CENTER, PA / ACCESSWIRE / May 9, 2024 / Halberd Corporati
Halberd's Patented LDN+ Drug Has Begun Pre-Pilot Trials With Military Veterans
08:00am, Tuesday, 30'th Apr 2024
LDN+ Drug Designed to Combat PTSD and Suicidal Ideation JACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd Corporation (OTC PINK:HALB) announced a pre-pilot study of its patented LDN+ drug wit
JACKSON CENTER, PA / ACCESSWIRE / April 4, 2024 / Halberd Corporation's (OTC PINK:HALB) Patented LDN+ Drug hits an enormous milestone as it enters a significant Safety Trial Protocol under a CRADA con
Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray Testing
08:00am, Thursday, 08'th Feb 2024
JACKSON CENTER, PA / ACCESSWIRE / February 8, 2024 / Halberd Corporation's (OTC PINK:HALB) Traumatic Brain Injury (TBI) mitigating nasal spray testing protocols at Mississippi State University (MSU) w
JACKSON CENTER, PA / ACCESSWIRE / February 6, 2024 / Halberd Corporation's (OTC PINK:HALB) and Athena GTX's executives interviewed on "The Street Reports," discuss the relationship between Halberd and
Halberd Corporation 2023 Year-End CEO Update and 2024 Goals
08:00am, Thursday, 11'th Jan 2024
JACKSON CENTER, PA / ACCESSWIRE / January 11, 2024 / Halberd Corporation (OTC PINK:HALB) made significant advances in its technology development and accomplished major business goals during the second
Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX
08:00am, Tuesday, 09'th Jan 2024
Athena will employ its successful history of securing government contracts, spearheading such initiatives JACKSON CENTER, PA / ACCESSWIRE / January 9, 2024 / Halberd Corporation (OTC PINK:HALB) is thr
Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com
08:00am, Wednesday, 13'th Dec 2023
Peter Croden, CrodenHealth Chairman, previously executive with Pharmacia & Upjohn (Pfizer), Upjohn Canada, Upjohn Global Animal Health, NephRx, and Parnell Pharmaceuticals Holdings, Ltd. Endeavors to
Halberd Corporation Plans to Extend Research Partnership with Mississippi State University
08:00am, Wednesday, 15'th Nov 2023
MSU Research for Halberd to Transcend the TBI Nasal Spray JACKSON CENTER, PA / ACCESSWIRE / November 15, 2023 / Halberd Corporation (OTC PINK:HALB) is in talks with Mississippi State University (MSU)
Hartman, CEO, and Dr. Felder, CTO of Halberd Corp, Featured on The Street Reports Podcast
08:00am, Tuesday, 10'th Oct 2023
JACKSON CENTER, PA / ACCESSWIRE / October 10, 2023 / Halberd Corporation (OTC PINK:HALB) Chairman, President and CEO William A. Hartman and Chief Technology Officer, Dr Mitchell S.
Halberd's Traumatic Brain Injury (TBI) Testing Results Replicated at Mississippi State University (MSU)
08:00am, Wednesday, 04'th Oct 2023
JACKSON CENTER, PA / ACCESSWIRE / October 4, 2023 / Halberd Corporation's (OTC PINK:HALB) proprietary nasal spray testing results to mitigate the effects of Traumatic Brain Injury (TBI) at Mississippi
Halberd and Athena GTX Collaborate on Advanced Traumatic Brain Injury (TBI) Monitoring and Applications for Government Contracts
08:00am, Wednesday, 20'th Sep 2023
JACKSON CENTER, PA / ACCESSWIRE / September 20, 2023 / Halberd Corporation (OTC PINK:HALB) and Athena GTX, Inc, of Johnston, Iowa commenced collaboration on critical development of submissions for gov
